Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122705) titled 'Observational Clinical Study of Remimazolam Besylate versus Propofol for Sedation in Critically Ill Patients Undergoing Operative Examinations' on April 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shijiazhuang People's Hospital
Condition:
None
Intervention:
Remimazolam besylate group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-30
Target Sample Size: Remimazolam besylate group:42;Propofol group:42;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=316867
Published by HT Digit...